We are analyzing https://link.springer.com/article/10.1007/s11883-012-0291-7.

Title:
How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy? | Current Atherosclerosis Reports
Description:
Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical trials will only be replicated in real-life if patients adhere to the prescribed treatment regimen. But, about half of patients discontinue statin therapy within the first year, and adherence decreases with time. Patient, physician and healthcare system-related factors play a role in this problem. Recent studies have focused more on the patients’ perspectives on non-adherence. Adverse events are cited as the most common cause of statin discontinuation; thus, the healthcare provider must be willing to ally and dialogue with patients to address concerns and assess the risks and benefits of continued statin therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

google, scholar, article, pubmed, statin, adherence, cas, therapy, patients, risk, cardiovascular, study, cholesterol, med, patient, heart, disease, coronary, statins, medication, diabetes, care, drug, drugs, trial, cardiol, trials, adverse, health, lowering, lancet, data, longterm, treatment, lipoprotein, circulation, effects, content, information, improve, events, intervention, randomised, safety, privacy, cookies, analysis, breslow, access, lowdensity,

Topics {✒️}

low-density lipoprotein cholesterol month download article/chapter low hdl/high triglycerides phytosterol/-stanol-enriched margarines elevated c-reactive protein large internet-based survey randomised placebo-controlled trial cholesterol-lowering statin drugs lipid-lowering medication adherence long-term statin therapy improve long-term adherence long-term medication adherence full article pdf improve patient compliance lloyd-jones dm privacy choices/manage cookies adverse drug effects low health literacy lipid lowering medication lipid-lowering medication golomb ba lowering ldl cholesterol high blood cholesterol health care reform early statin compliance long-term treatment advanced lipoprotein testing bmc fam pract pharmacoepidemiol drug saf internet-based survey major vascular events important safety label meeting lipid targets patient education curr atheroscler rep lower ldl-cholesterol coronary heart disease statin drugs access prescribed treatment regimen epidemiol community health managed care population acute coronary syndromes long-term adherence coronary artery disease long-term persistence increased cardiovascular risk functional foods enriched cv risk threshold major cardiovascular disease focus-group study

Questions {❓}

How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
Is there a relationship between early statin compliance and a reduction in healthcare utilization?
Medication adherence: WHO cares?
Statins for all by the age of 50 years?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
         description:Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical trials will only be replicated in real-life if patients adhere to the prescribed treatment regimen. But, about half of patients discontinue statin therapy within the first year, and adherence decreases with time. Patient, physician and healthcare system-related factors play a role in this problem. Recent studies have focused more on the patients’ perspectives on non-adherence. Adverse events are cited as the most common cause of statin discontinuation; thus, the healthcare provider must be willing to ally and dialogue with patients to address concerns and assess the risks and benefits of continued statin therapy.
         datePublished:2012-12-09T00:00:00Z
         dateModified:2012-12-09T00:00:00Z
         pageStart:1
         pageEnd:8
         sameAs:https://doi.org/10.1007/s11883-012-0291-7
         keywords:
            Statin
            Adherence
            Compliance
            Patient–physician communication
            Adverse events
            Lipid-lowering
            Angiology
            Cardiology
         image:
         isPartOf:
            name:Current Atherosclerosis Reports
            issn:
               1534-6242
               1523-3804
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Current Science Inc.
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Patricia Maningat
               affiliation:
                     name:The Rockefeller University
                     address:
                        name:The Rockefeller University, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bruce R. Gordon
               affiliation:
                     name:The Rogosin Institute
                     address:
                        name:The Rogosin Institute, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jan L. Breslow
               affiliation:
                     name:The Rockefeller University
                     address:
                        name:The Rockefeller University, New York, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
      description:Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical trials will only be replicated in real-life if patients adhere to the prescribed treatment regimen. But, about half of patients discontinue statin therapy within the first year, and adherence decreases with time. Patient, physician and healthcare system-related factors play a role in this problem. Recent studies have focused more on the patients’ perspectives on non-adherence. Adverse events are cited as the most common cause of statin discontinuation; thus, the healthcare provider must be willing to ally and dialogue with patients to address concerns and assess the risks and benefits of continued statin therapy.
      datePublished:2012-12-09T00:00:00Z
      dateModified:2012-12-09T00:00:00Z
      pageStart:1
      pageEnd:8
      sameAs:https://doi.org/10.1007/s11883-012-0291-7
      keywords:
         Statin
         Adherence
         Compliance
         Patient–physician communication
         Adverse events
         Lipid-lowering
         Angiology
         Cardiology
      image:
      isPartOf:
         name:Current Atherosclerosis Reports
         issn:
            1534-6242
            1523-3804
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Current Science Inc.
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Patricia Maningat
            affiliation:
                  name:The Rockefeller University
                  address:
                     name:The Rockefeller University, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bruce R. Gordon
            affiliation:
                  name:The Rogosin Institute
                  address:
                     name:The Rogosin Institute, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jan L. Breslow
            affiliation:
                  name:The Rockefeller University
                  address:
                     name:The Rockefeller University, New York, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Atherosclerosis Reports
      issn:
         1534-6242
         1523-3804
      volumeNumber:15
Organization:
      name:Current Science Inc.
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Rockefeller University
      address:
         name:The Rockefeller University, New York, USA
         type:PostalAddress
      name:The Rogosin Institute
      address:
         name:The Rogosin Institute, New York, USA
         type:PostalAddress
      name:The Rockefeller University
      address:
         name:The Rockefeller University, New York, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Patricia Maningat
      affiliation:
            name:The Rockefeller University
            address:
               name:The Rockefeller University, New York, USA
               type:PostalAddress
            type:Organization
      name:Bruce R. Gordon
      affiliation:
            name:The Rogosin Institute
            address:
               name:The Rogosin Institute, New York, USA
               type:PostalAddress
            type:Organization
      name:Jan L. Breslow
      affiliation:
            name:The Rockefeller University
            address:
               name:The Rockefeller University, New York, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:The Rockefeller University, New York, USA
      name:The Rogosin Institute, New York, USA
      name:The Rockefeller University, New York, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(205)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

9.67s.

LINK . SPRINGER . COM {}